Lunai Bioworks Inc. (LNAI)
Nasdaq: LNAI · Pharmaceutical Preparations · Suite 906 Los Angeles, CA · filing with the SEC since 2011
Filings
340 filings since 2017 beside 158 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Jun 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Sep 28, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 13, 2026.
Filings a yearinsider forms included
42343554881124631
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 14 times in the last 36 months, the newest Nov 12, 2026.Listing warning from its exchange (8-K item 3.01): 13 times in the last 36 months, the newest Oct 23, 2026.Warning not to rely on past financial statements (8-K item 4.02): 2 times in the last 36 months, the newest Feb 19, 2025.SEC letters: 11 in the last 36 months, the newest Nov 4, 2024.A late-filing notice, Form NT 10-K, filed Sep 29, 2026.A late-filing notice, Form NT 10-Q, filed Feb 18, 2025.A late-filing notice, Form NT 10-K, filed Oct 1, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 23, 2026
8-K items 3.01, 5.02, 7.01, 8.01, 9.01
Listing warning from its exchange; Officer or director change; Investor disclosure (Regulation FD); Other event · Current report
Oct 16, 2026
May 11, 2026
8-K/A item 3.01
Listing warning from its exchange · Current report, amended
Apr 27, 2026
May 1, 2026
8-K items 1.01, 2.01, 3.01, 3.02, 3.03, 5.03, 9.01
Major agreement signed; Purchase or sale of a business completed; Listing warning from its exchange; Shares sold without registration; Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Apr 27, 2026
Mar 30, 2026
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
Mar 24, 2026
Feb 12, 2026
8-K items 3.01, 7.01
Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report
Feb 6, 2026
40 of 340 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.